Neuromuscular Blockade Clinical Trial
Official title:
Bilateral Transversus Abdominis Plane Block Versus Atracurium During Laparoscopic Gynecology Procedures. Do we Really Still Need the Systemic Neuromuscular Blocking Agents?
A monocentric, prospective, randomized controlled trial, including patients proposed for a laparoscopic gynecologic surgery comparing the muscular relaxing effect of a bilateral ultrasound-guided Transversus Abdominis Plane block to usual neuromuscular blockade agent (Atracurium)
We conducted a monocentric randomized single blinded controlled trial for six months starting
from February 2015 until July 2015. Patients undergoing laparoscopic gynecologic procedures
were included and randomly assigned in two groups receiving either an ultrasound guided TAP
block (TAP group) or usual Neuromuscular blockade curare type: Atracurium (TRAC group).
Randomization was simple and the allocation sequence was generated by a random number table
via computer. The surgeon in charge was blinded about the performance of a TAP block.
Anesthesia protocol was almost the same in the two groups apart from the TAP block
performance in the study group and the use of the neuromuscular blockade . No premedication
was given to before the procedure. Monitoring was standard with a 5 leads electrocardioscope,
non-invasive arterial pressure, pulsed oximetry (SpO2) and pressure of end tidal expired CO2
(PetCO2). Peripheral venous access was obtained and a 0.9 % saline vascular prefilling was
done via an 18 or a 16 Gauges (G) percutaneous line in the non-dominant superior member. In
the TRAC group, induction was given with 2.5 mg Propofol, 3 γ/kg Fentanyl and 0.6 mg/kg
Atracurium. In The TAP group general anesthesia was induced, after a 3 minutes
pre-oxygenation, with 3 γ/kg fentanyl, 2.5 mg/kg Propofol and 1mg/kg Suxamethonium.
Thereafter the TAP block was performed under ultrasonography guidance with a Samsung
(MySonoU6) transportable device and a linear high frequency 5-12 Megahertz transducer. The
probe was oriented transversely on the antero-lateral abdominal wall and the image depth was
set between 4 and 6 cm. Once anatomic structures were visualized and well distinct, the probe
was moved posteriorly until the mid-axillary line between the 12th rib and the iliac crest.
Operator should be able to identify from top to bottom: the subcutaneous fat tissue
(hypo-echogenic), External Oblic Abdominal Muscle (EOAM), Internal Oblic Abdominal Muscle
(IOAM), Transverse Abdominis Muscle (TAM) (heterogeneous), peritoneum (hyper-echogenic) and
underneath intraabdominal organs both moving with respiration. The junction between the
posterior fascia of the IOAM and the anterior fascia of the TAM is also hyper-echogenic and
represent the region of interest as it is the local anesthetic injection site. The puncture
was proceeded with 100 mm lenght needle 21 G (Vygon, France) needle witch progressed
obliquely through the abdominal wall. Operator realized an in plane ultrasound guided
approach. As soon as the tip of the needle was placed in the junction between the IOAM and
TAM and the aspiration test negative, a priming of 3 ml local anesthetic injection was used
in order to unsure a correct position of the needle. In this case the injectate would appear
as a hypo-echogenic oval well-shaped volume spreading between the two muscle layers. An
inaccurate injection was suspected by the absence of the described image. Intramuscular
injection could appear as a poorly defined hyper-echogenic image within the muscle. Once the
correct position verified, the rest of the 20 ml of the 2.5% bupivacaine is injected. The
contralateral block was performed equally. Anesthesia was maintained by a total intravenous
anesthesia in both groups. Fentanyl was systematically reinjected every 30 minutes and
Propofol was infused at 8-10 mg/kg/h. In the TRAC group, Atracurium reinjections were guided
by the monitoring of the NMB every 20 minute at a dose equal to 0.1mg/kg to be reevaluated
after 5 minutes. In the TAP group, a rescue injection of NMB agent was indicated in case of
diaphragmatic contractions, surgeons' complaint or patients' movement after optimization of
narcosis by increasing propofol infusing speed to a maximum of 5 mg/kg/h beyond the baseline
speed and checking analgesia. In both groups patients were ventilated on a volume assisted
mode with 50 % of inspired fraction of Oxygen and 4-6 cmH2O of positive end expiratory
pressure (PEEP) aiming to get an SpO2>95%. Tidal volume and respiratory rate were set as to
maintain a PetCO2 between 30 and 45 mmHg. A nasogastric tube was inserted before trocars
introduction (T0). Patients from the two study groups had a postoperative analgesia
prescription including acetaminophen (1g/6h), Ketoprofen (100 mg/12h) and Nefopam (20mg/4h).
A 5 mg subcutaneous morphine injection was considered as rescue analgesia.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05558969 -
The Effect of Magnesium Use in Reversal of Neuromuscular Block With Sugammadex
|
N/A | |
Completed |
NCT03168308 -
Sugammadex vs. Neostigmine for Neuromuscular Blockade Reversal in Thoracic Surgical Patients
|
Phase 4 | |
Not yet recruiting |
NCT03978780 -
Erector Spinae Block vs. Placebo Block Study
|
N/A | |
Completed |
NCT02912039 -
Electromyographic Assessment of the TetraGraph in Normal Volunteers
|
||
Completed |
NCT02892045 -
Mindray Neuromuscular Transmission Transducer
|
||
Completed |
NCT03427385 -
Minimum Local Anesthetic Dose for Adductor Canal Block
|
N/A | |
Completed |
NCT01450813 -
The Effect of Neuromuscular Blockade on the Composite Variability Index (CVI) During Laryngoscopy
|
N/A | |
Completed |
NCT00535496 -
Relation Between TOF-Watch® SX and a Peripheral Nerve Stimulator After 4.0 mg.Kg-1 Sugammadex (P05698)
|
Phase 3 | |
Recruiting |
NCT05794503 -
Postoperative Urinary Retention After Reversal of Neuromuscular Block by Neostigmine Versus Sugammadex
|
Early Phase 1 | |
Not yet recruiting |
NCT05993390 -
Pharmacological Reversal of Neuromuscular Blockade in Critically Ill Patients
|
N/A | |
Recruiting |
NCT04609410 -
Bleeding in Laparoscopic Liver Surgery
|
N/A | |
Terminated |
NCT03649672 -
The Validity and Tolerability of Awake Calibration of the TOF Watch SX Monitor
|
N/A | |
Completed |
NCT05687253 -
Evaluation of Intubation Conditions Following BX1000 or Rocuronium in Subjects Undergoing Surgery
|
Phase 2 | |
Completed |
NCT05474638 -
Comparison of Mechanomyographic 100 Versus 200 Hz 5 Second Tetanic Fade Ratios During Neuromuscular Block Recovery
|
N/A | |
Completed |
NCT05120999 -
Comparison of Onset of Neuromuscular Blockade With Electromyographic and Acceleromyographic Monitoring
|
||
Completed |
NCT03572413 -
The Effect of Low Pressure Pneumoperitoneum During Laparoscopic Colorectal Surgery on Innate Immune Homeostasis.
|
Phase 4 | |
Completed |
NCT03608436 -
The Effect of Low Pressure Pneumoperitoneum During Laparoscopic Colorectal Surgery on Early Quality of Recovery
|
Phase 4 | |
Recruiting |
NCT02930629 -
Residual Block in Postoperative Anaesthetic Care Unit
|
N/A | |
Completed |
NCT02932254 -
Magnesium Sulfate Effect Following the Reversal of Neuromuscular Blockade Induced by Rocuronium With Sugammadex
|
Phase 4 | |
Completed |
NCT01828385 -
Effect of Magnesium on the Recovery Time of Neuromuscular Blockade With Sugammadex
|
Phase 4 |